You are using an outdated browser. Please upgrade your browser to improve your experience.


A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
Target Activities
Items per page:
1 – 2 of 2